ETFIQData as of Nov 18, 2026. · etfiq.com/funds/tmed

TMED Fact Sheet: T. Rowe Price Health Care ETF

Share
$33.12
close, Nov 18, 2026

Over the year to Nov 18, 2026, TMED returned +13.6% in total and charged 0.44% a year.

1-year total return
+13.6%
XLV +20.7% to Nov 18, 2026
Expense ratio
0.44%
a year
Net assets
$41m
on Nov 17, 2026
Net flow, last 2 trading days
+$3.5m
daily basis to Nov 16, 2026

Growth of $10,000, 1 year

TMED $11,355 +13.6% · XLV $12,070 +20.7% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month−1.3%
3 months−9.7%
Year to date+11.4%
1 year+13.6%
Since launch+32.5%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
ELI LILLY & CO16.71%
UNITEDHEALTH GROUP INC6.52%
GILEAD SCIENCES INC4.43%
THERMO FISHER SCIENTIFIC INC4.12%
DANAHER CORP2.96%
CENCORA INC2.75%
AGILENT TECHNOLOGIES INC2.61%
ALNYLAM PHARMACEUTICALS INC2.60%
INTUITIVE SURGICAL INC2.44%
INSULET CORP2.38%

TMED top ten by weight, 47.5% of the fund, of its 96 equity positions, from the holdings filed for Jun 30, 2026.

Facts

Equity fund · Actively managed · First traded Jun 12, 2025 · Benchmark S&P Health Care Select Sector Index, measured by XLV, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, TMED Fact Sheet: T. Rowe Price Health Care ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/tmed/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/tmed.